Abstract
Many processes are included within the scope of the term matrix degradation. Specialized matrices such as bone and cartilage, which provide structural support for the animal, are dynamic structures that resorb or expand in response to hormonal stimuli. The enzymatic machinery for the degradation of large quantities of collagen and other matrix components must be under the appropriate transcriptional regulation in the controlling cell type. Similarly, if a whole organ or tissue is removed, such as during uterine and mammary involution, enzymes are required that are capable of lysing basement membranes and interstitial matrix and processing cellular debris so that all the components can be absorbed by scavenging cell types. Matrix degradation is also a part of invasive cellular migration, when cells displace gels of interstitial molecules or cross basement membranes, the natural barriers to cell migration. In contrast to the involution reaction, lysis associated with cell motility is a limited reaction that leaves the bulk of the matrix intact and is directed only at the “structural kingpins,” those molecules that constitute a barrier to cell displacement. Cell growth, division, and expansion also demand flexibility in the growth matrix, such as that associated with tissue regeneration and during development. Matrix is also a reservoir of growth factors and possible morphogens, and rather specific cleavage reactions directed against carrier molecules like vitronectin and heparan sulfate may have a role in determining the course of further cell growth and proteolysis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adham, I. M., Klemm, U., Maier, W. M., Hoyer-Fender, S., Tsaousidou, S., and Engel, W., 1989, Molecular cloning of preproacrosin and analysis of its expression pattern in spermatogenesis, Eur. J. Biochem. 182:563–568.
Alexander, C. M., and Werb, Z., 1989, Proteinases and extracellular matrix remodeling, Curr. Opin. Cell Biol. 1:974–982.
Andrews, H. J., Edwards, T. A., Cawston, T. E., and Hazleman, B. L., 1989, Transforming growth factor-beta causes partial inhibition of interleukin 1-stimulated cartilage degradation in vitro, Biochem. Biophys. Res. Commun. 162:144–150.
Antonelli-Orlidge, A., Saunders, K. B., Smith, S. R., and D’Amore, P. A., 1989, An activated form of transforming growth factor ß is produced by cocultures of endothelial cells and pericytes, Proc. Natl. Acad. Sci. USA 86:4544–4548.
Apodaca, G., Rutka, J. T., Bouhana, K., Berens, M. E., Giblin, J. R., Rosenblum, M. L., McKerrow, J. H., and Banda, M. J., 1990, Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells, Cancer Res. 50:2322–2329.
Astedt, B., Hagerstrand, I., and Lecander, I., 1986, Cellular localization in placenta of placental type plasminogen activator inhibitor, Thromb. Haemost. 56:63–65.
Banda, M. J., Rice, A. G., Griffin, G. L., and Senior, R. M., 1988, Alpha-1 proteinase inhibitor is a neutrophil chemoattractant after proteolytic inactivation by macrophage elastase, J. Biol. Chem. 263:4481–4484.
Beers, W. H., 1975, Follicular plasminogen and plasminogen activator and the effect of plasmin on ovarian follicle wall, Cell 6:379–386.
Behrendtsen, O., Alexander, C. M., and Werb, Z., 1991, Metalloproteinases mediate extracellular matrix degradation by cells from mouse blastocyst outgrowths, Development submitted.
Bejarano, P. A., Noelken, M. E., Suzuki, K., Hudson, B. G., and Nagase, H., 1988, Degradation of basement membranes by human matrix metalloproteinase-3 (stromelysin), Biochem. J. 256:413–419.
Bernhard, E. J., Muschel, R. J., and Hughes, E. N., 1990, Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells, Cancer Res. 50:3872–3877.
Birkedal-Hansen, B., Moore, W. G., Taylor, R. E., Bhown, A. S., and Birkedal-Hansen, H., 1988, Monoclonal antibodies to human fibroblast procollagenase. Inhibition of enzymatic activity, affinity purification of the enzyme, and evidence for clustering of epitopes in the NH2-terminal end of the activated enzyme, Biochemistry 27:6751–6758.
Blasi, F., Vassalli, J.-D., and Dano, K., 1987, Urokinase-type plasminogen activator: Proenzyme, receptor, and inhibitors, J. Cell Biol. 104:801–804.
Boone, T. C., Johnson, M. J., De Clerck, Y. A., and Langley, K. E., 1990, cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases, Proc. Natl. Acad. Sci. USA 87:2800–2804.
Brannstrom, M., Woessner, J. F., Jr., Koos, R. D., Sear, C. H. J., and LeMaire, W. J., 1988, Inhibitors of mammalian tissue collagenase and metalloproteinases suppress ovulation in the perfused rat ovary, Endocrinology 122:1715–1721.
Breathnach, R., Matrisian, L. M., Gesnel, M. C., Staub, A., and Leroy, P., 1987, Sequences coding for part of oncogene-induced transin are highly conserved in a related rat gene, Nucleic Acids Res. 15:1139–1151.
Brenner, C. A., Adler, R. R., Rappolee, D. A., Pedersen, R. A., and Werb, Z., 1989, Genes for extracellular matrix-degrading metalloproteinases and their inhibitor, TIMP, are expressed during early mammalian development, Genes Dev. 3:848–859.
Brinckerhoff, C. E., Plucinska, I. M., Sheldon, L. A., and O’Connor, G. T., 1986, Half-life of synovial cell collagenase mRNA is modulated by phorbol myristate acetate but not by all-trans-retonoic acid or dexamethasone, Biochemistry 25:6378–6384.
Brown, C. C., Hembry, R. M., and Reynolds, J. J., 1989, Immunolocalisation of metalloproteinases and their inhibitor in the rabbit growth plate, J. Bone J. Surg. 71:580–593.
Busso, N., Huarte, J., Vassalli, J.-D., Sappino, A.-P., and Belin, D., 1989, Plasminogen activators in the mouse mammary gland: Decreased expression during lactation, J. Biol. Chem. 264:7455–7457.
Campbell, E. J., and Campbell, M. A., 1988, Pericellular proteolysis by neutrophils in the presence of proteinase inhibitors: Effects of substrate opsonization, J. Cell Biol. 106:667–676.
Caroni, P., and Schwab, M. E., 1988, Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter, Neuron 1:85–96.
Case, J. P., Lafyatis, R., Remmers, E. F., Kumkumian, G. K., and Wilder, R. L., 1989, Transin/stromelysin expression in rheumatoid synovium. A transformation-associated metalloproteinase secreted by phenotypically invasive synoviocytes, Am. J. Pathol. 135:1055–1064.
Cawston, T. E., Curry, V. A., Clark, I. M., and Hazleman, B. L., 1990, Identification of a new metalloproteinase inhibitor that forms tight-binding complexes with collagenase, Biochem. J. 269:183–187.
Chambers, T. J., 1988, The regulation of osteoclastic development and function, Ciba Found. Symp. 136:92–107.
Chelberg, M. K., Tsilibary, E. C., Hauser, A. R., and McCarthy, J. B., 1989, Type IV collagen-mediated melanoma cell adhesion and migration: Involvement of multiple, distinct domains of the collagen molecule, Cancer Res. 49:4796–4802.
Chiu, R., Angel, P., and Karin, M., 1989, Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun, Cell 59:979–986.
Clark, I. M., and Cawston, T. E., 1989, Fragments of human fibroblast collagenase. Purification and characterization, Biochem. J. 263:201–206.
Coulombe, B., and Skup, D., 1988, In vitro synthesis of the active tissue inhibitor of metalloproteinases encoded by a complementary DNA from virus-infected murine fibroblasts, J. Biol. Chem. 263:1439–1443.
Cubellis, M. V., Wun, T. C., and Blasi, F., 1990, Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1, EMBO J. 9:1079–1085.
Dano, K., Andreasen, P. A., Grondahl-Hansen, J., Kristensen, P., Nielsen, L. S., and Skriver, L., 1985, Plasminogen activators, tissue degradation, and cancer, Adv. Cancer Res. 44:139–266.
De Clerck, Y. A., Yean, T.-D., Ratskin, B. J., Lu, H. S., and Langley, K. E., 1989, Purification and characterisation of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells, J. Biol. Chem. 264:17445–17453.
Del Rosso, M., Fibbi, G., Dini, G., Grappone, C., Pucci, M., Caldini, R., Magnelli, L., Fimiani, M., Lotti, T., and Panconsei, E., 1990, Role of specific membrane receptors in urokinase-dependent migration of human keratinocytes, J. Invest. Dermatol. 94:310–316.
Desrochers, P. E., and Weiss, S. J., 1988, Proteolytic inactivation of alpha-l-proteinase inhibitor by a neutrophil metalloproteinaseJ. Clin. Invest. 81:1646–1650.
Dodge, G. R., and Poole, A. R., 1989, Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin-1J. Clin. Invest. 83:647–661.
Edwards, D. R., Waterhouse, P., Holman, M. L., and Denhardt, D. T., 1986, A growth-responsive gene (16C8) in normal mouse fibroblasts homologous to a human collagenase inhibitor with erythroid-potentiating activity: Evidence for inducible and constitutive transcripts, Nucleic Acids Res. 14:8863–8877.
Ellis, S. M., Nabeshima, K., and Biswas, C., 1989, Monoclonal antibody preparation and purification of a tumor cell collagenase-stimulatory factor, Cancer Res. 49:3385–3391.
Estreicher, A., Muhlhauser, J., Carpentier, J.-L., Orci, L., and Vassalli, J.-D., 1990, The receptor for urokinase type plasminogen activator polarises expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes, J. Cell Biol. 111:783–792.
Farrell, D. H., Wagner, S. L., Yuan, R. H., and Cunningham, D. D., 1988, Localisation of protease nexin-1 on the fibroblast extracellular matrix, J. Cell. Physiol. 134:179–188.
Fawcett, J. W., and Housden, E., 1990, The effects of protease inhibitors on axon growth through astrocytes, Development 109:59–66.
Fisher, S. J., Cui, T. Y., Zhang, L., Hartman, L., Grahl, K., Zhang, G. Y., Tarpey, J., and Damsky, C. H., 1989, Adhesive and degradative properties of human placental cytotrophoblast cells in vitro, J. Cell Biol. 109:891–902.
Flenniken, A. M., and Williams, B. R. G., 1990, Developmental expression of the endogenous TIMP gene and a TIMP-lacZ fusion gene in transgenic mice, Genes Dev. 4:1094–1106.
Folkman, J., and Klagsbrun, M., 1987, Angiogenic factors, Science 235:442–447.
Gewert, D. R., Coulombe, B., Castelino, M., Skup, D., and Williams, B. R. G., 1987, Characterization and expression of a murine gene homologous to human EPA/TIMP: A virus-induced gene in the mouse, EMBO J. 6:651–657.
Gloor, S., Odink, K., Guenther, J., Nick, H., and Monard, D., 1986, A glia-derived neurite promoting factor with protease inhibitory activity belongs to the protease nexins, Cell 47:687–693.
Gonzalez, A.-M., Buscaglia, M., Ong, M., and Baird, A., 1990, Distribution of basic fibroblast growth factor in the 18-day rat fetus: Localisation in the basement membranes of diverse tissues, J. Cell Biol. 110:753–765.
Gray, D. J., Gardner, E., and O’Rahilly, R., 1957, The prenatal development of the skeleton and joints of the human hand, Am. J. Anat. 101:169–223.
Grillo, H. C., and Gross, J., 1967, Collagenolytic activity during mammalian wound repair, Dev. Biol. 15:300–317.
Gross, J., 1966, How tadpoles lose their tails, J. Invest. Dermatol. 47:274–277.
Gross, J., 1981, An essay on biological degradation of collagen, in: Cell Biology of Extracellular Matrix (E. D. Hay, ed.), pp. 217–258, Plenum Press, New York.
Gunja-Smith, Z., Nagase, H., and Woessner, J. F., Jr., 1989, Purification of the neutral proteoglycandegrading metalloproteinase from human articular cartilage tissue and its identification as stromelysin matrix metalloproteinase-3, Biochem. J. 258:115–119.
Gutman, A., and Wasylyk, B., 1990, The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites, EMBO J. 9:2241–2246.
Hardy, D. M., Schoots, A. F., and Hedrick, J. L., 1989, Caprine acrosin. Purification, characterization and proteolysis of the porcine zona pellucida, Biochem. J. 257:447–453.
Hebert, C. A., and Baker, J. B., 1988, Linkage of extracellular plasminogen activator to the fibroblast cytoskeleton: Colocalization of cell surface urokinase with vinculin, J. Cell Biol. 106:1241–1247.
Heine, U., Munoz, E. F., Flanders, K. C., Ellingsworth, L. R., Lam, H. Y., Thompson, N. L., Roberts, A. B., and Sporn, M. B., 1987, Role of transforming growth factor-beta in the development of the mouse embryo, J. Cell Biol. 105:2861–2876.
Heine, U. I., Munoz, E. F., Flanders, K. C., Roberts, A. B., and Sporn, M. B., 1990, Colocalization of TGF beta-1 and collagen I and collagen III, fibronectin and glycosaminoglycans during lung branching morphogenesis, Development 109:29–36.
Herron, G. S., Banda, M. J., Clark, E. J., Gavrilovic, J., and Werb, Z., 1986, Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors, J. Biol Chem. 261:2814–2818.
Hiramoto, S. A., and Cunningham, D. D., 1988, Effects of fibroblasts and endothelial cells on inactivation of target proteases by protease nexin-1, heparin cofactor II and Cl-inhibitor, J. Cell. Biochem. 36:199–207.
Horowitz, S., Dafni, N., Shapiro, D. L., Holm, B. A., Notter, R. H., and Quible, D. J., 1989, Hyperoxic exposure alters gene expression in the lung: Induction of the tissue inhibitor of metalloproteinases mRNA and other RNAs, J. Biol. Chem. 264:7092–7095.
Huarte, J., Belin, D., Bosco, D., Sappino, A.-P., and Vassalli, J.-D., 1987, Plasminogen activator and mouse spermatozoa: Urokinase synthesis in the male genital tract and binding of the enzyme to the sperm cell surface, J. Cell Biol. 104:1281–1289.
Huber, A. R., and Weiss, S. J., 1989, Disruption of the subendothelial basement membrane during neutrophil diapedesis in an in vitro construct of a blood vessel wallJ. Clin. Invest. 83:1122–1136.
Huebner, K., Isobe, M., Gasson, J. C., Golde, D. W., and Croce, C. M., 1986, Localization of the gene encoding human erythroid-potentiating activity to chromosome region Xp11.1-Xp11.4, Am. J. Hum. Genet. 38:819–826.
Huffer, W. E., 1988, Morphology and biochemistry of bone remodeling: Possible control by vitamin D, parathyroid hormone, and other substancesLab. Invest. 59:418–442.
Ingber, D. E., and Folkman, J., 1989, Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: Role of extracellular matrix, J. Cell Biol. 109:317–330.
Khokha, R., Waterhouse, P., Yagel, S., Lala, P. K., Overall, C. M., Norton, G., and Denhardt, D. T., 1989, Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells, Science 243:947–950.
Krane, S. M., Conca, W., Stephenson, M. L., Amento, E. P., and Goldring, M. B., 1990, Mechanisms of matrix degradation in rheumatoid arthritis, Ann. N.Y. Acad. Sci. 580:340–354.
Krystosek, A., and Seeds, N. W., 1981, Plasminogen activator release at the neuronal growth cone, Science 213:1532–1534.
Krystosek, A., and Seeds, N. W., 1986, Normal and malignant cells, including neurons, deposit plasminogen activator on the growth substrata, Exp. Cell Res. 166:31–46.
Kumkumian, G. K., Lafyatis, R., Remmers, E. F., Case, J. P., Kim, S. J., and Wilder, R. L., 1989, Platelet-derived growth factor and IL-1 interactions in rheumatoid arthritis. Regulation of synoviocyte proliferation, prostaglandin production, and collagenase transcription, J. Immunol. 143:833–837.
Laiho, M., and Keski-Oja, J., 1989, Growth factors in the regulation of pericellular proteolysis: A review, Cancer Res. 49:2533–2553.
Larsson, L.-I., Skriver, L., Nielsen, L. S., Grondahl-Hansen, J., Kristensen, P., and Dano, K., 1984, Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse, J. Cell Biol. 98:894–903.
Leibovich, S. J., and Ross, R., 1975, The role of the macrophage in wound repair: A study with hydrocortisone and antimacrophage serum, Am. J. Pathol. 78:71–100.
Lepage, T., and Gache, C., 1990, Early expression of a collagenase-like hatching enzyme gene in the sea urchin embryo, EMBO J. 9:3003–3012.
Librach, C. L., Werb, Z., Fitzgerald, M. L., Chiu, K., Corwin, N. M., Esteves, R. A., Grobelny, D., Galardy, R., Damsky, C. H., and Fisher, S. J., 1991, 92 kD type IV collagenase mediates invasion of human cytotrophoblasts, J. Cell Biol. 113:437–449.
Lindner, J., Guenther, J., Nick, H., Zinser, G., Antonicek, H., Schachner, M., and Monard, D., 1986, Modulation of granule cell migration by a glia-derived protein, Proc. Natl. Acad. Sci. USA 83:4568–4571.
Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C. M., and Shafie, S., 1980, Metastatic potential correlates with enzymatic degradation of basement membrane collagen, Nature 284:67–68.
Lyons, J. G., Siew, K., and O’Grady, R. L., 1989, Cellular interactions determining the production of collagenase by a rat mammary carcinoma cell line, Int. J. Cancer 43:119–125.
MacNaul, K. L., Chartrain, N., Lark, M., Tocci, M. J., and Hutchinson, N. I., 1990, Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinase-1 in rheumatoid human synovial fibroblasts, J. Biol Chem. 265:17238–17245.
Matrisian, L. M., and Hogan, B. L. M., 1990, Growth factor-regulated proteases and extracellular matrix remodeling during mammalian development, Curr. Top. Dev. Biol. 24:219–259.
McCachren, S. S., Haynes, B. F., and Niedel, J. E., 1990, Localization of collagenase mRNA in rheumatoid arthritis synovium by in situ hybridization histochemistry, J. Clin. Immunol. 10:19–27.
McKerrow, J. H., and Doenhoff, M. J., 1988, Schistosome proteases, Parasitol. Today 4:334–340.
McKerrow, J. H., Skanari, J., Brown, M., Brindley, P., Railey, J., Weiss, N., and Resnick, S. D., 1989, Proteolytic enzymes as mediators of parasite invasion of skin, in: Models in Dermatology, Vol. 4 (H. I. Maibach and N. J. Lowe, eds.), p. 276–284 Karger, Basel.
Merwin, J. R., Anderson, J. M., Kocher, O., van Itallie, C. M. and Madri, J. A., 1990, Transforming growth factor 131 modulates extracellular matrix organization and cell—cell junctional complex formation during in vitro angiogenesis, J. Cell. Physiol. 142:117–128.
Mignatti, P., Robbins, E., and Rifkin, D. B., 1986, Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade, Cell 47:487–498.
Mignatti, P., Tsuboi, R., Robbins, E., and Rifkin, D. B., 1989, In vitro angiogenesis on the human amniotic membrane: Requirement for basic fibroblast growth factor-induced proteinases, J. Cell Biol. 108:671–682.
Mikuni-Takagaki, Y., and Cheng, Y.-S., 1987, Metalloproteinases in endochondral bone formation: Appearance of tissue inhibitor-resistant metalloproteinases, Arch. Biochem. Biophys. 259:576–588.
Moller, C. C., and Wassarman, P. M., 1989, Characterization of a proteinase that cleaves zona pellucida glycoprotein ZP2 following activation of mouse eggs, Dev. Biol. 132:103–112.
Monteagudo, C., Merino, M. J., San-Juan, J., Liotta, L. A., and Stetler-Stevenson, W. G., 1990, Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue, Am. J. Pathol. 136:585–592.
Montesano, R., and Orci, L., 1985, Tumor-promoting phorbol esters induce angiogenesis in vitro, Cell 42:469–477.
Montesano, R., Pepper, M. S., Belin, D., Vassalli, J.-D., and Orci, L., 1988, Induction of angiogenesis in vitro by vanadate, an inhibitor of phosphotyrosine phosphatases, J. Cell. Physiol. 134:460–466.
Montesano, R., Pepper, M. S., Mohle-Steinlein, U., Risau, W., Wagner, E. F., and Orci, L., 1990, Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene, Cell 62:435–445.
Moscatelli, D., and Rifkin, D. B., 1988, Membrane and matrix localization of proteinases: A com-mon theme in tumor cell invasion and angiogenesis, Biochim. Biophys. Acta 948:67–85.
Nagase, H., Enghild, J. J., Suzuki, K., and Salvesen, G., 1990, Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate, Biochemistry 29:5783–5789.
Nomura, S., Hogan, B. L. M., Wills, A. J., Heath, J. K., and Edwards, D. R., 1989, Developmental expression of tissue inhibitor of metalloproteinase (TIMP) RNA, Development 105:575–583.
Okada, Y., Watanabe, S., Nakanishi, I., Kishi, J.-I., Hayakawa, T., Watorek, W., Travis, J., and Nagase, H., 1988, Inactivation of tissue inhibitor of metalloproteinase by neutrophil elastase and other serine proteinases, FEBS Lett. 229:157–160.
Ossowski, L., 1988, In vivo invasion of modified chorioallantoic membrane by tumor cells: The role of cell surface-bound urokinase, J. Cell Biol. 107:2437–2445.
Ossowski, L., and Reich, E., 1983, Antibodies to plasminogen activator inhibit human tumor metastasis, Cell 35:611–619.
Ossowski, L., Biegel, D., and Reich, E., 1979, Mammary plasminogen activator: Correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue, Cell 16:929–940.
Ostrowski, L. E., Finch, J., Krieg, P., Matrisian, L., Patskan, G., O’Connell, J. F., Phillips, J., Slaga, T. J., Breathnach, R., and Bowden, G. T., 1988, Expression pattern of a gene for a secreted metalloproteinase during late stages of tumor progression, Mol. Carcinogenesis 1:13–19.
Paganetti, P. A., Caroni, P., and Schwab, M. E., 1988, Glioblastoma infiltration into central nervous system tissue in vitro: Involvement of a metalloprotease, J. Cell Biol. 107:2281–2291.
Park, A. J., Matrisian, L. M., Kells, A. F., Pearson, R., Yuan, Z., and Navre, M., 1991, Mutational analysis of the transin (rat stromelysin) autoinhibitor region demonstrates a role for residues surrounding the cysteine switch, J. Biol. Chem. 266:1584–1590.
Patthy, L., 1985, Evolution of the proteases of blood coagulation and fibrinolysis by assembly from modules, Cell 41:657–663.
Pepper, M. S., Vassalli, J.-D., Montesano, R., and Orci, L., 1987, Urokinase-type plasminogen ac-tivator is induced in migrating capillary endothelial cells, J. Cell Biol. 105:2535–2541.
Pepper, M. S., Spray, D. C., Chanson, M., Montesano, R., Orci, L., and Meda, P., 1989, Junctional communication is induced in migrating capillary endothelial cells, J. Cell Biol. 109:3027–3038.
Pepper, M. S., Belin, D., Montesano, R., Orci, L., and Vassalli, J.-D., 1990, Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro, J. Cell Biol. 111:743–755.
Peppin, G. J., and Weiss, S. J., 1986, Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils, Proc. Natl. Acad. Sci. USA 83:4322–4326.
Perlmutter, D. H., and Pierce, J. A., 1989, The alpha-1-antitrypsin gene and emphysema, Am. J. Physiol. 257:L146–162.
Perona, R. M., and Wassarman, P. M., 1986, Mouse blastocysts hatch in vitro by using a trypsin-like proteinase associated with cells of mural trophectoderm, Dev. Biol. 114:42–52.
Pollanen, J., 1989, Down-regulation of plasmin receptors on human sarcoma cells by glucocor-ticoids, J. Biol. Chem. 264:5628–5632.
Pollanen, J., Hedman, K., Nielsen, L. S., Dano, K., and Vaheri, A., 1988, Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts, J. Cell Biol. 106:87–95.
Qian, J. J., Liu, X., Zha, J., Sorensen, K. R., Scaria, P. V., and Bhatnagar, R. S., 1990, How do cells see collagen? J. Cell Biol. 111:24a.
Reich, R., Thompson, E. W., Iwamoto, Y., Martin, G. R., Deason, J. R., Fuller, G. C., and Miskin, R., 1988, Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells, Cancer Res. 48:3307–3312.
Rifas, L., Halstead, L. R., Peck, W. A., Avioli, L. V., and Welgus, H. G., 1989, Human osteoblasts in vitro secrete tissue inhibitor of metalloproteinases and gelatinase but not interstitial collagenase as major cellular products, J. Clin. Invest. 84:686–694.
Roberts, A. B., Heine, U. I., Flanders, K. C., and Sporn, M. B., 1990, Transforming growth factor-beta. Major role in regulation of extracellular matrix, Ann. N.Y. Acad. Sci. 580:225–232.
Saksela, O., and Rifkin, D. B., 1988, Cell-associated plasminogen activation: Regulation and physiological functions, Annu. Rev. Cell Biol. 4:93–126.
Saksela, O., and Rifkin, D. B., 1990, Release of basic fibroblast growth factor—heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity, J. Cell Biol. 110:767–775.
Saksela, O., Moscatelli, D., and Rifkin, D. B., 1987, The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells, J. Cell Biol. 105:957–963.
Sanchez-Lopez, R., Nicholson, R., Gesnel, M.-C., Matrisian, L. M., and Breathnach, R., 1988, Structure—function relationships in the collagenase family member transin, J. Biol. Chem. 263:11892–11899.
Sappino, A. P., Huarte, J., Belin, D., and Vassalli, J. D., 1989, Plasminogen activators in tissue remodeling and invasion: mRNA localisation in mouse ovaries and implanting embryos, J. Cell Biol. 109:2471–2479.
Sato, Y., Tsuboi, R., Lyons, R., Moses, H., and Rifkin, D. B., 1990, Characterisation of the activation of latent TGF 3 by co-cultures of endothelial cells and pericytes or smooth muscle cells: A self-regulating system, J. Cell Biol. 111:757–763.
Schleef, R. R., Wagner, N. V., Sinha, M., and Loskutoff, D. J., 1986, A monoclonal antibody that does not recognize tissue-type plasminogen activator bound to its naturally occurring inhibitor, Thromb. Haemost. 56:328–332.
Schultz, R. M., Silberman, S., Persky, B., Bajkowski, A. S., and Carmichael, D. F., 1988, Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16–F10 melanoma cells, Cancer Res. 48:5539–5545.
Sottile, J., Mann, D. M., Diemer, V., and Millis, A. J. T., 1989, Regulation of collagenase and collagenase mRNA production in early-and late-passage human diploid fibroblasts, J. Cell. Physiol. 138:281–290.
Springman, E. B., Angleton, E. L., Birkedal-Hansen, H., and Van Wart, H. E., 1990, Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a “cysteine switch” mechanism for activation,Proc. Natl. Acad. Sci. USA 87:364–368.
Starkey, J. R., Stanford, D. R., Magnuson, J. A., Hamner, S., Robertson, N. P., and Gasic, G. J., 1987, Comparison of basement membrane matrix degradation by purified proteases and by metastatic tumor cells, J. Cell. Biochem. 35:31–49.
Stein, B., Rahmsdorf, H. J., Steffen, A., Litfin, M., and Herrlich, P., 1989, UV-induced DNA damage is an intermediate step in UV-induced expression of human immunodeficiency virus type 1, collagenase, c-fos, and metallothionein, Mol. Cell. Biol. 9:5169–5181.
Stetler-Stevenson, W. G., Krutzsch, H. C., and Liotta, L. A., 1989, Tissue inhibitor of metallopro-teinase (TIMP-2): A new member of the metalloproteinase inhibitor family, J. Biol. Chem. 264:17374–17378.
Stetler-Stevenson, W. G., Brown, P. D., Onisto, M., Levy, A. T., and Liotta, L. A., 1990, Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumour cell lines and human tumor tissues, J. Biol. Chem. 265:13933–13938.
Strickland, S., Reich, E., and Sherman, M. I., 1976, Plasminogen activator in early embryogenesis: Enzyme production by trophoblast and parietal endoderm, Cell 9:231–240.
Stump, D. C., Lijnen, H. R., and Collen, D., 1986, Purification and characterization of a novel low molecular weight form of single-chain urokinase-type plasminogen activator, J. Biol. Chem. 261:17120–17126.
Sullivan, L. M., and Quigley, J. P., 1986, An anticatalytic monoclonal antibody to avian plasminogen activator: Its effect on behavior of RSV-transformed chick fibroblasts, Cell 45:905–915.
Talhouk, R. S., Chin, J. R., Unemori, E. N., Werb, Z., and Bissell, M. J., 1991, Proteinases of the mammary gland: Developmental regulation in vivo and vectorial secretion in culture, Development 112:439–449.
Terranova, V. P., Maslow, D., and Markus, G., 1989, Directed migration of murine and human tumor cells to collagenases and other proteases, Cancer Res. 49:4835–4841.
Thomson, B. M., Atkinson, S. J., McGarrity, A. M., Hembry, R. M., Reynolds, J. J., and Meikle, M. C., 1989, Type I collagen degradation by mouse calvarial osteoblasts stimulated with 1,25-dihydroxyvitamin D-3: Evidence for a plasminogen—plasmin—metalloproteinase activation cascade, Biochim. Biophys. Acta 1014:125–132.
Unemori, E. N., Bouhana, K. S., and Werb, Z., 1990, Vectorial secretion of extracellular matrix proteins, matrix-degrading proteinases, and tissue inhibitor of metalloproteinases by endothelial cells, J. Biol. Chem. 265:445–451.
Vaes, G., 1988, Cellular biology and biochemical mechanism of bone resorption. A review of recent developments on the formation, activation, and mode of action of osteoclasts, Clin. Orthop. Relat. Res. 231:239–271.
Vance, B. A., Kowalski, C. G., and Brinckerhoff, C. E., 1989, Heat shock of rabbit synovial fibroblasts increases expression of mRNAs for two metalloproteinases, collagenase and stromelysin, J. Cell Biol. 108:2037–2043.
Van Wart, H. E., and Birkedal-Hansen, H., 1990, The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family, Proc. Natl. Acad. Sci. USA 87:5578–5582.
Wagner, S. L., Lau, A. L., and Cunningham, D. D., 1989, Binding of protease nexin-1 to the fibroblast surface alters its target proteinase specificity, J. Biol. Chem. 264:611–615.
Werb, Z., 1989, Proteinases and matrix degradation, in: Textbook of Rheumatology, 3rd ed. (W. N. Kelley, E. D. Harris, Jr., S. Ruddy, and C. B. Sledge, eds.), pp. 300–321, W. B. Saunders, Philadelphia.
Werb, Z., Mainardi, C. L., Vater, C. A., and Harris, E. D., Jr., 1977, Endogenous activation of latent collagenase by rheumatoid synovial cells: Evidence for a role of plasminogen activator, N. Engl. J. Med. 296:1017–1023.
Werb, Z., Tremble, P. M., Behrendtsen, O., Crowley, E., and Damsky, C. H., 1989, Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression, J. Cell Biol. 109:877–889.
Werb, Z., Tremble, P., and Damsky, C. H., 1990, Regulation of extracellular matrix degradation by cell—extracellular matrix interactions, Cell Differ. Dev. 32:299–306.
Wilhelm, S. M., Collier, I. E., Marmer, B. L., Eisen, A. Z., Grant, G. A., and Goldberg, G. I., 1989, SV-40 transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages, J. Biol. Chem. 264:17213–17221.
Wiman, B., Almquist, A., Sigurdardottir, O., and Lindahl, T., 1988, Plasminogen activator inhibitor 1 (PAI) is bound to vitronectin in plasma, FEBS Lett. 242:125–128.
Woessner, J. F., Jr., and Taplin, C. J., 1988, Purification and properties of a small latent matrix metalloproteinase of the rat uterus, J. Biol. Chem. 263:16918–16925.
Wu, H., Byrne, M. H., Stacey, A., Goldring, M. B., Birkhead, J. R., Jaenisch, R., and Krane, S. M., 1990, Generation of collagenase-resistant collagen by site-directed mutagenesis of murine pro alpha 1(I) collagen gene, Proc. Natl. Acad. Sci. USA 87:5888–5892.
Yang, E. Y., and Moses, H. L., 1990, Transforming growth factor ß1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane, J. Cell Biol. 111:731–741.
Zucker, S., 1988, A critical appraisal of the role of proteolytic enzymes in cancer invasion: Emphasis on tumor surface proteinases, Cancer Invest. 6:219–231.
Zucker, S., Moll, U. M., Lysik, R. M., DiMassimo, E. I., Stetler-Stevenson, W. G., Liotta, L. A., and Schwedes, J. W., 1990, Extraction of type IV collagenase/gelatinase from plasma membranes of human cancer cells, Int. J. Cancer 46:1137–1142.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Alexander, C.M., Werb, Z. (1991). Extracellular Matrix Degradation. In: Hay, E.D. (eds) Cell Biology of Extracellular Matrix. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3770-0_9
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3770-0_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6680-5
Online ISBN: 978-1-4615-3770-0
eBook Packages: Springer Book Archive